Drugs / \[2H31\] palmitate
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT05745441 | Jul 2023 → Mar 2028 expected | obesity disorder, prediabetes syndrome | Johns Hopkins University | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | \[2H31\] palmitate | “Stable isotope of oral \[2H31\] palmitate to measure fat oxidation, given with dinner before DLMO” NCT05745441 ↗ |
| Modality | Diagnostic / imaging agent | “Stable isotope of oral \[2H31\] palmitate to measure fat oxidation” NCT05745441 ↗ |
| Route | Oral | “Stable isotope of oral \[2H31\] palmitate” NCT05745441 ↗ |